MYCN
MYCN blocking
anti-MYCN antigene PNA
immune network
immune signature
immune system
neuroblastoma
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2021
2021
Historique:
received:
10
11
2020
accepted:
04
01
2021
entrez:
15
3
2021
pubmed:
16
3
2021
medline:
16
3
2021
Statut:
epublish
Résumé
A wide range of malignancies presents
Identifiants
pubmed: 33718189
doi: 10.3389/fonc.2021.625207
pmc: PMC7951059
doi:
Types de publication
Journal Article
Langues
eng
Pagination
625207Informations de copyright
Copyright © 2021 Raieli, Di Renzo, Lampis, Amadesi, Montemurro, Pession, Hrelia, Fischer and Tonelli.
Déclaration de conflit d'intérêts
RT and AP are co-founders and shareholders of Biogenera. Authors SR, SL and CA are employed by Biogenera. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Cancer Discov. 2018 Feb;8(2):150-163
pubmed: 29358508
Nat Rev Cancer. 2018 Jun;18(6):389-400
pubmed: 29632319
Nat Rev Mol Cell Biol. 2018 Jun;19(6):349-364
pubmed: 29618831
EMBO J. 1989 Jan;8(1):133-6
pubmed: 2653809
Nature. 1986 Feb 27-Mar 5;319(6056):780-3
pubmed: 2419762
Cell Res. 2017 Aug;27(8):1034-1045
pubmed: 28685773
Biom J. 2010 Feb;52(1):70-84
pubmed: 19937997
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nat Rev Cancer. 2003 Mar;3(3):203-16
pubmed: 12612655
Oncoimmunology. 2015 Apr 2;4(9):e1019981
pubmed: 26405592
Cancer Res. 2019 Dec 15;79(24):6166-6177
pubmed: 31615807
Nat Biotechnol. 2019 Jul;37(7):773-782
pubmed: 31061481
Cancer Gene Ther. 2021 Feb;28(1-2):5-17
pubmed: 32457487
Cancer Cell. 2009 Jan 6;15(1):67-78
pubmed: 19111882
Mol Cancer Ther. 2005 May;4(5):779-86
pubmed: 15897242
Cancer Cell. 2019 Oct 14;36(4):385-401.e8
pubmed: 31564637
Cancer Cell. 2016 Jan 11;29(1):1-2
pubmed: 26766585
Oncoimmunology. 2017 Apr 28;6(6):e1320626
pubmed: 28680756
Cold Spring Harb Perspect Med. 2013 Oct 01;3(10):a014415
pubmed: 24086065
J Natl Cancer Inst. 2015 May 13;107(7):
pubmed: 25972604
Int J Oncol. 2018 Mar;52(3):787-803
pubmed: 29328367
CA Cancer J Clin. 2014 Mar-Apr;64(2):83-103
pubmed: 24488779
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Science. 1984 Jun 8;224(4653):1121-4
pubmed: 6719137
Crit Rev Oncol Hematol. 2019 Jun;138:38-43
pubmed: 31092383
Clin Cancer Res. 2017 Aug 1;23(15):4462-4472
pubmed: 28270499
Cancer Lett. 2016 Sep 28;380(1):304-14
pubmed: 26597947
Nat Immunol. 2017 May;18(5):583-593
pubmed: 28263321
Biomed Res Int. 2018 Feb 25;2018:1812535
pubmed: 29682521
Clin Cancer Res. 2012 Feb 1;18(3):796-807
pubmed: 22065083
Science. 2017 May 26;356(6340):
pubmed: 28495876
N Engl J Med. 1985 Oct 31;313(18):1111-6
pubmed: 4047115
Oncogene. 2018 Sep;37(39):5269-5280
pubmed: 29855615
Nature. 1984 May 31-Jun 6;309(5967):458-60
pubmed: 6728001
Front Immunol. 2020 Feb 13;11:167
pubmed: 32117298
Leuk Lymphoma. 1993 Oct;11(3-4):197-205
pubmed: 8260894
J Pediatr Surg. 2004 Oct;39(10):1506-11
pubmed: 15486895
Nat Biotechnol. 2018 Dec 03;:
pubmed: 30531897
Nat Rev Dis Primers. 2016 Nov 10;2:16078
pubmed: 27830764
Clin Cancer Res. 2010 Apr 1;16(7):2036-45
pubmed: 20332316
Cell. 1986 Dec 5;47(5):667-74
pubmed: 3096575
Oncology. 2008;75(3-4):127-33
pubmed: 18791328
Cancer. 2017 Oct 1;123(19):3807-3815
pubmed: 28608950
Oncoimmunology. 2017 Apr 20;6(6):e1316439
pubmed: 28680748
Nature. 2015 Aug 6;524(7563):47-53
pubmed: 26168399
Front Immunol. 2018 Oct 16;9:2380
pubmed: 30459759
Cell Commun Signal. 2020 Sep 7;18(1):142
pubmed: 32894141
Nature. 2016 Jul 06;535(7611):246-51
pubmed: 27383785
Stat Appl Genet Mol Biol. 2005;4:Article17
pubmed: 16646834
PLoS One. 2019 Jun 12;14(6):e0218269
pubmed: 31188873
Sci Rep. 2015 Oct 14;5:15179
pubmed: 26462617
Cancer. 2017 Nov 1;123(21):4224-4235
pubmed: 28696504
Front Oncol. 2013 Jun 26;3:167
pubmed: 23805414
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
Semin Cancer Biol. 2018 Oct;52(Pt 2):53-65
pubmed: 29196189
Cell Cycle. 2017 Aug 18;16(16):1489-1498
pubmed: 28737478
Curr Drug Metab. 2019;20(13):1014-1022
pubmed: 31878853
J Clin Oncol. 1999 Jul;17(7):2264-79
pubmed: 10561284
Nat Commun. 2013;4:2612
pubmed: 24113773
Immunotherapy. 2019 Jun;11(9):831-850
pubmed: 31094257
Am J Clin Exp Immunol. 2017 Jun 15;6(4):66-75
pubmed: 28695059
J Clin Invest. 2015 Sep;125(9):3335-7
pubmed: 26325031
Clin Cancer Res. 2016 Mar 15;22(6):1364-70
pubmed: 26534966
Cancer Res. 2005 Sep 15;65(18):8308-16
pubmed: 16166307
Genes (Basel). 2017 Mar 30;8(4):
pubmed: 28358317
Front Oncol. 2012 Oct 12;2:141
pubmed: 23091802
Nucleic Acids Res. 2020 Jan 8;48(D1):D93-D100
pubmed: 31598675
Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12640-5
pubmed: 15314238
Front Immunol. 2019 May 24;10:1084
pubmed: 31178859